Company news

Share this article:
A spokesperson for GlaxoSmithKline told reporters that the company will make an announcement to US employees tomorrow about a reorganization, prompting press speculation about cuts to US-based sales forces.

Genzyme and Osiris Therapeutics have announced a partnership to develop and commercialize Prochymal and Chondrogen, two late-stage adult stem cell treatments. Osiris will commercialize the two treatments in the US and Canada, with Genzyme marketing the treatments in other countries.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.